Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
Clinical trial NCT03556592 · COMPLETED
Trial details
- NCT number
- NCT03556592
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2020-03-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.